Type 2 Diabetes: Advanced Glucose Monitoring
- Chicago-continuous glucose monitors (CGMs) are transforming how individuals manage type 2 diabetes (T2D).Kevin Sayer, CEO of Dexcom, speaking at the American Diabetes Association's 85th Scientific Sessions, highlighted the...
- Sayer emphasized that CGM technology not onyl reduces diabetes-related stress but also boosts patient confidence.
- Beyond the immediate benefits, CGMs show promise in improving long-term cardiovascular and kidney health outcomes.
Continuous glucose monitors (CGMs) are revolutionizing type 2 diabetes management by providing a real-time “scoreboard” of your blood sugar levels. This groundbreaking technology empowers individuals to understand how their choices impact their health, leading to more informed decisions. cgms not only reduce diabetes-related stress but also boost patient confidence, perhaps resulting in cost savings through fewer doctor visits and medication adjustments. Clinical trials consistently show A1c reductions and improved patient outcomes. The integration of AI further enhances CGM capabilities,promoting personalized feedback. news Directory 3 provides a full briefing about how these advanced glucose monitoring devices are the future of T2D management. discover what’s next in this evolving field.
Continuous Glucose Monitors Offer a “Scoreboard” for Type 2 Diabetes
Updated June 23, 2025
Chicago-continuous glucose monitors (CGMs) are transforming how individuals manage type 2 diabetes (T2D).Kevin Sayer, CEO of Dexcom, speaking at the American Diabetes Association’s 85th Scientific Sessions, highlighted the complete insights these devices provide. CGMs act as a real-time “scoreboard,” showing patients how medications, meals, and lifestyle choices directly impact their blood sugar levels, offering actionable insights for diabetes management.
Sayer emphasized that CGM technology not onyl reduces diabetes-related stress but also boosts patient confidence. The continuous data stream empowers individuals to make informed decisions about their health. Furthermore, the use of a continuous glucose monitor can potentially lead to cost savings by reducing the need for frequent doctor visits and enabling more precise medication adjustments.
Beyond the immediate benefits, CGMs show promise in improving long-term cardiovascular and kidney health outcomes. Ongoing advancements in artificial intelligence (AI) are further enhancing the capabilities of these devices, offering personalized feedback and support.
“What a CGM provides them with is literally a scoreboard that tells them what their actions do for their diabetes health,” Sayer said. “They see a big spike because they didn’t take their meds. They learn I need to take my meds every day.”
Sayer noted that even basic glucose numbers provide substantially more details than patients typically have with traditional finger-stick methods. Dexcom’s G7, for example, features AI-based meal identification, matching meals with glucose spikes to provide valuable insights for people with type 2 diabetes.
Clinical trials have consistently demonstrated that CGM adoption leads to A1c reduction, as average glucose values decrease. Studies also reveal increased patient confidence,reduced diabetes stress,and potential cost reductions due to fewer hospitalizations and medication adjustments. The role of continuous glucose monitor in improving cardiovascular and kidney health is also increasingly evident.
What’s next
The future of CGM technology includes further integration of AI to provide even more personalized and actionable insights for individuals managing type 2 diabetes, potentially leading to improved health outcomes and a better quality of life.